Advertisement
EXFY vs ONMD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXFY is a StrongBuy and ONMD is a Hold.
EXFY in upward trend: 10-day moving average broke above 50-day moving average on October 16, 2026
The 10-day moving average for EXFY crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on EXFY as a result. In 62 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence (MACD) for EXFY just turned positive on October 09, 2026. Looking at past instances where EXFY's MACD turned positive, the stock continued to rise in 30 of 39 cases over the following month. The odds of a continued upward trend are 77%.
EXFY moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +5.67% 3-day Advance, the price is estimated to grow further. Considering data from situations where EXFY advanced for three days, in 165 of 225 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
The Aroon Indicator entered an Uptrend today. In 94 of 136 cases where EXFY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 69%.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EXFY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.728) is normal, around the industry mean (-1.734). P/E Ratio (-15.000) is within average values for comparable stocks, (15.183). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.074) among similar stocks. P/S Ratio (1.573) is also within normal values, averaging (71.128).
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. EXFY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 85 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EXFY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ONMD's RSI Indicator ascends from oversold territory
The RSI Oscillator for ONMD moved out of oversold territory on October 14, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 19 similar instances when the indicator left oversold territory. In 19 of the 19 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on ONMD as a result. In 43 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 52%.
The Moving Average Convergence Divergence (MACD) for ONMD just turned positive on October 21, 2026. Looking at past instances where ONMD's MACD turned positive, the stock continued to rise in 30 of 58 cases over the following month. The odds of a continued upward trend are 52%.
Following a +4.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where ONMD advanced for three days, in 113 of 149 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
ONMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
ONMD moved below its 50-day moving average on September 25, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ONMD crossed bearishly below the 50-day moving average on September 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ONMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for ONMD entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ONMD's P/B Ratio (-83.250) is very low in comparison to the industry average of (3.981). P/E Ratio (-2.906) is within average values for comparable stocks, (13.628). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. ONMD's P/S Ratio (23.529) is slightly higher than the industry average of (6.065).
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. ONMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ONMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
| EXFY | ONMD | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 44% |
| Momentum ODDS (%) | 1 day ago 71% | 1 day ago 52% |
| MACD ODDS (%) | 1 day ago 77% | 1 day ago 52% |
| TrendWeek ODDS (%) | 1 day ago 77% | 1 day ago 41% |
| TrendMonth ODDS (%) | 1 day ago 74% | 1 day ago 86% |
| Advances ODDS (%) | 2 days ago 73% | 3 days ago 76% |
| Declines ODDS (%) | 25 days ago 88% | 11 days ago 90% |
| BollingerBands ODDS (%) | N/A | 1 day ago 81% |
| Aroon ODDS (%) | 1 day ago 69% | 1 day ago 86% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EXFY’s FA Score shows that 1 FA rating(s) are green while ONMD’s FA Score has 2 green FA rating(s).
- EXFY’s FA Score: 1 green, 4 red.
- ONMD’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EXFY’s TA Score shows that 6 TA indicator(s) are bullish while ONMD’s TA Score has 5 bullish TA indicator(s).
- EXFY’s TA Score: 6 bullish, 2 bearish.
- ONMD’s TA Score: 5 bullish, 5 bearish.
Price Growth
EXFY (@Packaged Software) experienced а +6.53% price change this week, while ONMD (@Services to the Health Industry) price change was -4.25% for the same time period.
The average weekly price growth across all stocks in the @Packaged Software industry was -0.43%. For the same industry, the average monthly price growth was -3.98%, and the average quarterly price growth was +4.31%.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was -1.51%. For the same industry, the average monthly price growth was -3.63%, and the average quarterly price growth was +16.27%.
Reported Earning Dates
EXFY is expected to report earnings on Nov 05, 2026.
ONMD is expected to report earnings on Nov 13, 2026.
Industries' Descriptions
@Packaged Software (-0.43% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
@Services to the Health Industry (-1.51% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
Advertisement
EXFY and
Correlation & Price change
A.I.dvisor indicates that over the last year, EXFY has been loosely correlated with CLSK. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if EXFY jumps, then CLSK could also see price increases.
| Ticker / NAME | Correlation To EXFY | 1D Price Change % | ||
|---|---|---|---|---|
| EXFY | 100% | -2.30% | ||
| CLSK - EXFY | 53% Loosely correlated | -6.86% | ||
| COIN - EXFY | 47% Loosely correlated | -4.51% | ||
| RIOT - EXFY | 46% Loosely correlated | -8.06% | ||
| DOCS - EXFY | 44% Loosely correlated | +0.30% | ||
| HOOD - EXFY | 44% Loosely correlated | -5.25% | ||
More | ||||
ONMD and
Correlation & Price change
A.I.dvisor tells us that ONMD and EVCM have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ONMD and EVCM's prices will move in lockstep.
| Ticker / NAME | Correlation To ONMD | 1D Price Change % | ||
|---|---|---|---|---|
| ONMD | 100% | +9.53% | ||
| EVCM - ONMD | 24% Poorly correlated | +0.22% | ||
| HUCK - ONMD | 24% Poorly correlated | +2.50% | ||
| EXFY - ONMD | 23% Poorly correlated | -2.30% | ||
| PLTK - ONMD | 22% Poorly correlated | N/A | ||
| PRTH - ONMD | 22% Poorly correlated | N/A | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DEED | 20.64 | 0.17 | +0.83% |
| First Trust Securitized Plus ETF (DEED) | |||
| FAX | 12.95 | -0.04 | -0.31% |
| abrdn Asia-Pacific Income Fund | |||
| PPA | 154.53 | -1.29 | -0.83% |
| Invesco Aerospace & Defense ETF (PPA) | |||
| TYO | 14.74 | -0.49 | -3.22% |
| Direxion Daily 7-10 Year Treasury Bear 3X ETF (TYO) | |||
| EWO | 38.92 | -1.65 | -4.07% |
| iShares MSCI Austria ETF (EWO) | |||